본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma Kim Yun-Hee
(Cancer Molecular Imaging Branch)

Lee Yu Sun
(Cancer Molecular Imaging Branch)
. New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma. JOURNAL OF PROTEOME RESEARCH. 2024-01-31; 2024; 23(3):905~915. IF 3.8 (2023)
Environmental exposure to lead and cadmium are associated with triglyceride glucose index
()

Kim Tae Wol
(Division of Cancer Prevention)
. Environmental exposure to lead and cadmium are associated with triglyceride glucose index. Scientific Reports. 2024-01-30; 2024; 14(1):2496~. IF 3.8 (2023)
Association between kimchi consumption and obesity based on BMI and abdominal obesity in Korean adults: a cross-sectional analysis of the Health Examinees study
()

Jung Hye In
(Division of Cancer Prevention)
. Association between kimchi consumption and obesity based on BMI and abdominal obesity in Korean adults: a cross-sectional analysis of the Health Examinees study. BMJ OPEN. 2024-01-30; 2024; 14(2):e076650~. IF 2.4 (2023)
Skin Elaticity Measurement Using Finite Element Simulation with Shear Wave Elasticity Imaging Park Dae Woo
(Diagnostics & Therapeutics Technology Branch)

Park Dae Woo
(Diagnostics & Therapeutics Technology Branch)
. Skin Elaticity Measurement Using Finite Element Simulation with Shear Wave Elasticity Imaging. JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY. 2024-01-30; 2024; 19:1725~1731. IF 1.6 (2023)
Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized,Double-blind, Placebo-controlled, Parallel-group Study
()

Choi Yoon Jin
(Branch of Gastroenterology)
. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized,Double-blind, Placebo-controlled, Parallel-group Study. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY. 2024-01-30; 2024; 30(1):73~86. IF 3.3 (2023)
Infection-related Hospitalizations During Immune Checkpoint Inhibitor Treatment Without Immunosuppressants Lee Young Joo
(Targeted Therapy Branch)


()
. Infection-related Hospitalizations During Immune Checkpoint Inhibitor Treatment Without Immunosuppressants. JOURNAL OF IMMUNOTHERAPY. 2024-01-29; 2024; 47(4):139~147. IF 3.2 (2023)
Reciprocal longitudinal effects among Korean young adolescent’ negative peer relationships, social withdrawal, and smartphone dependence
()

Lee Hye Sun
(Cancer Information & Education Center)
. Reciprocal longitudinal effects among Korean young adolescent’ negative peer relationships, social withdrawal, and smartphone dependence. HELIYON. 2024-01-28; 2024; 10(3):e25188~. IF 3.4 (2023)
The impact of the implementation of a national policy on dementia on healthcare costs in older patients with dementia in Korea: a quasi-experimental difference-in-difference study
()

Kim Woo Rim
(Hospice Policy & Planning Team)
. The impact of the implementation of a national policy on dementia on healthcare costs in older patients with dementia in Korea: a quasi-experimental difference-in-difference study. Lancet Regional Health-Western Pacific. 2024-01-28; 2024; 44:101010~. IF 7.6 (2023)
Prospective analysis of pre and postoperative laboratory parameters associated with thrombosis in patients with ovarian cancer LIM MYONG CHEOL
(Department of Cancer Control and Population Health)

Shim Hyoeun
(Department of Laboratory Medicine)
. Prospective analysis of pre and postoperative laboratory parameters associated with thrombosis in patients with ovarian cancer. JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2024-01-28; 2024; 57(3):492~496. IF 2.3 (2023)
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression Lee Yeon Su
(Rare & Pediatric Cancer Branch)


()
. Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression. Clinical and Molecular Hepatology. 2024-01-26; 2024; 30(2):247~262. IF 14 (2023)